Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 2.400
0.00 (0.00%)
Sep 16, 2026, 1:17 PM CET
Biofrontera AG Market Cap
Biofrontera AG has a market cap or net worth of €14.58 million as of September 15, 2026. Its market cap has decreased by -13.67% in one year.
Market Cap
14.58M
Enterprise Value
10.84M
Revenue
13.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.40
ChartMarket Cap Chart
Since October 31, 2006, Biofrontera AG's market cap has decreased from 38.05M to 14.58M, a decrease of -61.67%. That is a compound annual growth rate of -4.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 14.58M | -1.64% |
| Dec 30, 2025 | 14.83M | 13.49% |
| Dec 30, 2024 | 13.07M | -48.94% |
| Dec 29, 2023 | 25.59M | -73.70% |
| Dec 30, 2022 | 97.31M | 15.92% |
| Dec 30, 2021 | 83.94M | -42.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 57.15B |
| Bayer Aktiengesellschaft | 47.32B |
| Siemens Healthineers AG | 42.55B |
| Fresenius SE & Co. KGaA | 25.37B |
| Pentixapharm Holding AG | 45.72M |
| MeVis Medical Solutions AG | 42.95M |
| aap Implantate AG | 24.62M |
| NanoRepro AG | 22.45M |